High blood sugar, particularly as seen in diabetes, is strongly linked to an increased risk of dementia, including Alzheimer’s disease and vascular dementia. Research consistently shows that individuals with diabetes have about a 60% higher chance of developing dementia compared to those without diabetes[1][2]. This connection is rooted in how elevated blood sugar and insulin resistance affect brain function and structure.
Diabetes, especially type 2 diabetes, involves insulin resistance—a condition where the body’s cells do not respond properly to insulin, leading to excess glucose in the bloodstream. This insulin resistance is not limited to peripheral tissues like muscle and liver but also occurs in the brain. When brain cells become insulin resistant, their ability to use glucose for energy diminishes, which is critical because the brain consumes roughly 20% of the body’s energy despite being only 2% of its weight[1]. This impaired glucose metabolism in the brain is thought to contribute to cognitive decline and dementia.
The term “type 3 diabetes” has been proposed to describe Alzheimer’s disease due to its strong association with brain insulin resistance and disrupted glucose metabolism[2]. In Alzheimer’s, insulin signaling pathways in the brain are disrupted, leading to problems such as amyloid-beta accumulation, tau protein abnormalities, neuroinflammation, and oxidative stress—all hallmark features of the disease. These molecular changes impair neuronal function and survival, accelerating cognitive decline[2].
Moreover, repeated episodes of low blood sugar (hypoglycemia), which can occur in diabetes management, are also linked to a higher risk of cognitive impairment and dementia[1]. This suggests that both high and unstable blood sugar levels can negatively impact brain health.
Vascular dementia, another common form of dementia, is also closely linked to diabetes because diabetes shares risk factors like hypertension, stroke, and obesity, which damage blood vessels supplying the brain[3]. This vascular damage can lead to reduced blood flow and oxygen to brain tissue, further contributing to cognitive decline.
The global burden of diabetes and dementia is significant and growing, especially as populations age. With over 589 million adults worldwide living with diabetes and approximately 57 million people affected by dementia, understanding and addressing the link between these conditions is critical for public health[3].
Emerging research is exploring therapeutic strategies targeting insulin resistance and glucose metabolism in the brain to potentially slow or prevent dementia progression. These include drugs that improve insulin sensitivity, reduce inflammation, and protect neuronal energy metabolism[2].
In summary, high blood sugar and insulin resistance play a central role in increasing dementia risk by impairing brain glucose use, promoting neurodegenerative changes, and damaging cerebral blood vessels. This evidence underscores the importance of managing blood sugar levels and metabolic health to protect cognitive function.
—
Sources:
[1] SciTechDaily, “10 Ways Diabetes and Dementia Are Shockingly Connected,” 2025
[2] PMC, “A systematic review on type 3 diabetes: bridging the gap between Alzheimer’s disease and diabetes,” 2025
[3] International Diabetes Federation, “The hidden link: diabetes, dementia and ageing populations,” 2025
